Clinic
Medical Center of the Rockies
Medical Center of the Rockies was paid $4.80M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is 99285, emergency room visit (most serious) — 34% of everything it billed.
33Billing provider infoMEDICAL CENTER OF THE ROCKIES
LOVELAND, CO 80538
LOVELAND, CO 80538
33aNPI1750392304assigned 08/10/2006
33bProvider typeEmergency Care Clinic/Center
28Total paid$4.80M
24GClaims120,135
24DCodes billed86
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Colorado
Rank by total paid#3 of 23
Median peer was paid$1.29M
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMPSON, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,726 | $1.46M | |
| 2019 | 25,043 | $938K | |
| 2020 | 7,137 | $272K | |
| 2021 | 22,637 | $1.05M | |
| 2022 | 15,337 | $545K | |
| 2023 | 11,810 | $352K | |
| 2024incomplete | 6,445 | $176K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 34% | 21,383 | 18,615 | $1.64M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 12,343 | 10,365 | $1.11M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8.8% | 7,469 | 6,726 | $420K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8.3% | 1,886 | 1,603 | $398K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.9% | 2,979 | 2,663 | $281K |
| 0002A | 4.7% | 2,646 | 2,462 | $224K | |
| 0001A | 3.5% | 1,975 | 1,841 | $169K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.7% | 5,554 | 5,049 | $130K |
| 80053 | Comprehensive metabolic panel | 1.9% | 4,952 | 4,257 | $92K |
| 0004A | 1.8% | 1,325 | 1,296 | $87K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,260 | 2,031 | $29K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 364 | 354 | $29K |
74 more codes
| 86140 | <1% | 819 | $24K | |
| 0064A | <1% | 280 | $19K | |
| 0003A | <1% | 184 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,945 | $15K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 31 | $10K |
| 0012A | <1% | 102 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,174 | $9K |
| 86769 | <1% | 213 | $9K | |
| 0054A | <1% | 278 | $9K | |
| 0071A | <1% | 75 | $7K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 91 | $6K |
| 0072A | <1% | 66 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 66 | $5K |
| 85652 | <1% | 784 | $5K | |
| 0352U | <1% | 226 | $5K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 53 | $4K |
| 80061 | Lipid panel | <1% | 118 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 146 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,533 | $3K |
| 0124A | <1% | 85 | $3K | |
| 85027 | <1% | 542 | $3K | |
| 82565 | <1% | 103 | $3K | |
| 86780 | <1% | 216 | $2K | |
| 80076 | <1% | 114 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 183 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 34 | $2K |
| 84484 | <1% | 124 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 82 | $1K |
| 87480 | <1% | 199 | $1K | |
| J3490 | Unclassified drugs | <1% | 8,012 | $1K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 95 | $1K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 439 | $1K |
| 87510 | <1% | 199 | $1K | |
| 73630 | <1% | 26 | $803.88 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 122 | $742.61 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 82 | $728.70 |
| 87660 | <1% | 199 | $633.86 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 24 | $588.84 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 12 | $546.84 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 182 | $410.54 |
| 82040 | <1% | 76 | $277.29 | |
| 71045 | Radiologic examination, chest; single view | <1% | 546 | $258.55 |
| 84075 | <1% | 74 | $144.46 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 923 | $140.98 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,140 | $125.07 |
| 81025 | <1% | 420 | $101.05 | |
| 84439 | <1% | 12 | $86.86 | |
| 84450 | <1% | 75 | $74.13 | |
| 84460 | <1% | 75 | $71.91 | |
| 81003 | <1% | 759 | $57.57 | |
| 82950 | <1% | 12 | $47.49 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,149 | $11.65 |
| 84703 | <1% | 13 | $10.26 | |
| 83690 | <1% | 342 | $5.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 112 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 448 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 645 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 0% | 60 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 133 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 101 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 26 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 13 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 135 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 47 | $0.00 |
| 80306 | 0% | 13 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 114 | $0.00 |
| 81001 | 0% | 490 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 647 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 65 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 12 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 14 | $0.00 |
| 82077 | 0% | 12 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMPSON, DAVID (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.